Accelerated outsourcing in Medtech: Why specialized biomaterials manufacturing matters more than ever

By: Ted Clineff, Sr. Director, Biomedical Product Lines, at dsm-firmenich

What if medical device manufacturers and MedTech companies could focus solely on their highest-value innovation and leave the rest to trusted experts?

Today, contract development and manufacturing (CDMO) partnerships are expanding as OEMs turn to specialized partners to innovate faster and scale efficiently.

This momentum isn’t just about adding capacity. It’s about securing deep technical expertise, especially in medical-grade biomaterials, where precision, compliance, and consistency are non-negotiable.

At Biomedical, we help customers design and manufacture smarter, sustainable devices with confidence from day one.

What’s driving the outsourcing surge?

OEMs are narrowing their focus to core technologies and seeking partners capable of handling complex, highly specialized manufacturing. This shift becomes especially clear during asset acquisitions. Companies often acquire valuable technologies that come with non-strategic manufacturing sites - facilities they no longer want, or need, to operate.

Instead of absorbing that burden, OEMs are increasingly opting for strategic transfers to expert CDMO partners. 

Biomedical is one such partner that strives to provide a seamless, reliable transition path that preserves quality but allows OEMs to concentrate their resources where they create the most value.

Why finding the right partner matters

So, what makes a good partner in this new landscape? In today’s environment, outsourcing isn’t just about finding available manufacturing space; it’s about finding a team with the knowledge, infrastructure, and global supply chain to reliably produce specialized biomaterials.

Our partners benefit from our decades of experience in areas such as medical-grade polymers, animal-derived tissues, and environmentally sensitive materials. This depth of expertise enables us to deliver high-performance biomaterials (components of implantable medical devices and medical devices) at scale.

But this expertise can’t be built overnight. It’s earned through long-term mastery of sourcing, processing, regulatory navigation, and controlled manufacturing - capabilities that are increasingly difficult for OEMs to maintain internally.

Turning outsourcing challenges into opportunities

Of course, outsourcing isn't without its hurdles. While outsourcing can unlock tremendous value, it also introduces new questions:

• Can the process scale reliably?
• What are the cost implications of transferring or adjusting materials?
• How do we manage timelines without compromising quality?

Tackling these challenges early and transparently is crucial. Our multi-disciplined project management office conducts rigorous intake and feasibility assessments to identify risks, map dependencies, and clarify the true “make vs. buy” decision. 

This approach gives customers a realistic view of the path forward well before any commitments are made.

Quality you can trust – end-to-end

In a highly regulated, performance-critical field, there is no room for error.  That’s why quality is the foundation of every decision we make. Our quality system isn’t confined to a department; it’s embedded into every action, every process, and every partnership.

We maintain strong supply agreements with critical suppliers, complete with auditing and notification requirements to ensure their standards mirror our own.

This end-to-end oversight culminates in a clear, collaborative quality agreement with each customer, thus establishing the transparency and trust that long-term CDMO-OEM relationships rely on.

Building for the future of medical device manufacturing

The world doesn't stand still, and neither do we. We are constantly evolving our CDMO offerings to meet the future needs of our current and future partners. That’s why we’re continuing to implement a global asset strategy and inclusive of this global mindsight we build out our innovation application labs to speed up collaboration around the world.

We're also responding to global trends. Tariff impacts have accelerated the demand/need for local manufacturing, and our customers are actively seeking this flexibility. Our growing global footprint is designed to provide just that - regional expertise and production, right where you need it.

Let’s build the future together

The shift toward strategic outsourcing is more than a trend; it's the future of medical device manufacturing and innovation. By partnering with a specialized biomaterials manufacturer, you can unlock new efficiencies, reduce complexity, and focus on what truly drives your business forward. It's about finding a partner who offers not just capacity, but confidence.

If you're looking for your next partner in this space, we’re ready to help.